Latest

antidepressants

This shows an older man opening a bottle of pills

·October 7, 2019·4 min read

Number of depressed over-65s unchanged but antidepressant use soars

The proportion of those aged 65 and older prescribed antidepressants has more than doubled over two decades, from 4.2% in the 90s to 10.7% in twenty years later. However, the prevalence of depression among the age group has dropped since the 90s from 7.9% to 6.8%.

Featured Neuroscience Psychology

·September 25, 2019·5 min read

AI helps scientists predict depression outcomes

Artificial intelligence technology was able to identify specific brain regions which were most important for predicting whether a person with depression would respond to SSRI antidepressants.

Featured Neuroscience Open Neuroscience Articles Psychology

·September 20, 2019·6 min read

Common antidepressant may not reduce depression symptoms, but does reduce anxiety

Sertraline (Zoloft), a commonly prescribed SSRI antidepressant, may not be as effective at treating depression within 6 weeks as previously thought. However, the drug is effective for treating anxiety symptoms.

Featured Neuroscience Psychology

·September 6, 2019·5 min read

How serotonin and a popular anti-depressant affect the gut’s microbiota

Serotonin and SSRIs like Prozac can have a major effect on gut bacteria. When exposed to serotonin, specific gut bacteria grew to higher levels. However, when exposed to SSRIs, the bacterium grew to much lower levels in mouse models.

Featured Neuroscience Psychology

·September 1, 2019·5 min read

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'.

Featured Neuroscience Psychology

·July 31, 2019·4 min read

Ketamine isn’t an opioid and treats depression in a unique way

A new study clarifies the mechanism behind how ketamine works as an antidepressant. Researchers say there is evidence to suggest ketamine binds to NMDA receptors, instead of opioid receptors. Reducing the belief that ketamine is an opioid may make patients with depression more open to using the treatment.

Featured Neuroscience Psychology

·July 26, 2019·3 min read

Red wine compound shows promise for treating depression and anxiety

Resveratrol, a compound found in red wine, may help to combat depression and anxiety. The compound inhibits PDE4, an enzyme induced bt excessive amounts of corticosterone, which causes depression-like symptoms in mouse models.

Featured Neurology Neuroscience Psychology

·July 23, 2019·6 min read

Obstructive sleep apnea may be one reason depression treatment doesn’t work

A potential link has been identified between obstructive sleep apnea (OSA) and major depressive disorder. Treating OSA may help to improve depressive symptoms, as well as reduce suicidal thoughts and improve sleep for those with insomnia.

Featured Neuroscience Psychology

·July 10, 2019·2 min read

How a popular antidepressant drug could rewire the brain

Fluoxetine rearranges nerve fibers in the hippocampus of mice, a new study reports.

Featured Neuroscience Psychology

·July 1, 2019·4 min read

Early warning signs of eating disorder revealed

A new study reveals several biomarkers for eating disorders that are apparent two years prior to diagnosis.

This shows a person with pills in their hand

Featured Neurology Neuroscience Open Neuroscience Articles Psychology

·June 25, 2019·4 min read

Common antidepressants interact with opioid med to lessen pain relief

SSRI antidepressants, such as Prozac and Paxil, interact with opioid medications to make them less effective at providing relief from chronic pain. Tramadol relies on activation of the CYP2D6 enzyme to control pain, but SSRIs inhibit this enzyme. Researchers suggest prescribing different classes of antidepressants which do not suppress the enzyme may benefit those in need of opioid medications. Alternatively, non-opioid pain killers should be considered for those who can not switch from SSRIs.

This shows a person with pills in their hands

Featured Neurology Neuroscience Open Neuroscience Articles

·June 24, 2019·6 min read

Commonly prescribed drugs could increase the risk of dementia

Anticholinergic drugs, commonly prescribed to treat a range of disorders, from Parkinson's disease to bladder conditions, may increase dementia risks. The increased risk was linked to anticholinergic antidepressants, antipsychotics, bladder control, epilepsy and Parkinson's disease medications. There were no increased risks associated with other types of anticholinergics, such as gastrointestinal drugs or antihistamines.

1 … 9 10 11 12 13 … 21

antidepressants

Number of depressed over-65s unchanged but antidepressant use soars

AI helps scientists predict depression outcomes

Common antidepressant may not reduce depression symptoms, but does reduce anxiety

How serotonin and a popular anti-depressant affect the gut’s microbiota

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Ketamine isn’t an opioid and treats depression in a unique way

Red wine compound shows promise for treating depression and anxiety

Obstructive sleep apnea may be one reason depression treatment doesn’t work

How a popular antidepressant drug could rewire the brain

Early warning signs of eating disorder revealed

Common antidepressants interact with opioid med to lessen pain relief

Commonly prescribed drugs could increase the risk of dementia

Losing Smell Triggers Severe Clinical Depression

Trauma Therapy Reverses PTSD in Psychosis Patients

Why We Are Misjudging How Childhood Trauma Changes the Body

Everyday Habit Changes Lowers Dementia Risk

Subscribe